Exchange: NASDAQ·Updated 07:30 PM EDT

AMPH News

News
all
press releases
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference PR Newswire RANCHO CUCAMONGA, Calif., Sept. 1, 2026 RANCHO CUCAMONGA, Calif., Sept. 1, 2026 /PRNewswire/ -- Amphastar...
PR Newswire
More News
Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris
Amphastar Pharmaceuticals, Sandoz and Viatris are positioned to benefit from new launches, biosimilars and a shift toward higher-value generics.
Zacks
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
The Medical - Generic Drugs industry gains from new launches, biosimilar momentum and portfolio shifts, despite pricing pressure and supply challenges.
Zacks
New Strong Sell Stocks for August 14th
AMPH, CHT and HE have been added to the Zacks Rank #5 (Strong Sell) List on August 14, 2026.
Zacks
Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates
Amphastar (AMPH) delivered earnings and revenue surprises of +37.88% and +1.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026 Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026 PR Newswire RANCHO CUCAMONGA, Calif., Aug. 6, 2026 Net revenues of $183.9 million for the three months ended June...
PR Newswire
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 PR Newswire RANCHO CUCAMONGA, Calif., July 29, 2026 RANCHO CUCAMONGA, Calif., July 29, 2026...
PR Newswire
BridgeBio Pharma (BBIO) Moves 15.1% Higher: Will This Strength Last?
BridgeBio Pharma (BBIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks

Advertisement|Remove ads.